HK Innoen’s K‑Cap 50 mg Gets World’s First EPD for Oral Drugs

HK Innoen’s GERD medication K‑Cap 50 mg became the first oral solid dosage drug globally to receive an Environmental Product Declaration, highlighting its sustainability credentials.

HK Innoen announced that its gastro‑esophageal reflux disease (GERD) treatment, K‑Cap 50 mg, has become the first oral solid dosage pharmaceutical product worldwide to obtain an Environmental Product Declaration (EPD). The company received the EPD certificate at a ceremony on 2 July in Oslo, Norway, co‑hosted by EPD‑Global and the International Sustainability Certification Institute. The EPD provides objective environmental performance data, allowing the product to demonstrate both market competitiveness and sustainability in overseas markets.

HK Innoen’s GERD drug K‑Cap 50 mg earns world’s first EPD for oral solid dosage

평점

평가 남기기

더 많은 기사

HK Innoen’s GERD drug K‑Cap 50 mg earns world’s first EPD for oral solid dosage

평점

평가 남기기

더 많은 기사

HK Innoen’s GERD drug K‑Cap 50 mg earns world’s first EPD for oral solid dosage